Hippocampal beta-amyloid reduces locus coeruleus glutamate and tyrosine hydroxylase

Brain Res Bull. 1994;35(5-6):485-91. doi: 10.1016/0361-9230(94)90162-7.

Abstract

The effects of intrahippocampally injected beta-amyloid protein (beta-AP) on glutamate- (Glu) and tyrosine hydroxylase (TH)-like immunoreactivities in the neurons of the locus coeruleus (LC) were studied in rats. A synthetic peptide or the vehicle alone was injected into the hippocampus as controls. All injections were made once a week (two or three injections; 3 nmol in 2 microliters of distilled water). Fluorescent microspheres (either alone or with one of the peptides) were also injected into the hippocampus to identify coeruleo-hippocampal neurons. The results revealed cell loss in the hippocampus at the site near beta-AP or control peptide deposition. Furthermore, in beta-AP/microsphere injected animals, only 22.4% and 49.6% of hippocampal projection neurons contained Glu and TH, respectively, compared to 88.4% and 85.3% in the animals that received control peptide with microspheres. Our results suggest that beta-AP has an effect on noradrenergic cells whose axons project to the hippocampus. These effects may contribute to the TH cell loss in the LC of Alzheimer's brains.

MeSH terms

  • Amyloid beta-Peptides / administration & dosage
  • Amyloid beta-Peptides / pharmacology*
  • Animals
  • Glutamic Acid / metabolism*
  • Hippocampus / drug effects
  • Hippocampus / physiology*
  • Immunohistochemistry
  • Injections
  • Locus Coeruleus / drug effects
  • Locus Coeruleus / enzymology
  • Locus Coeruleus / metabolism*
  • Male
  • Neural Pathways / cytology
  • Neural Pathways / physiology
  • Rats
  • Rats, Sprague-Dawley
  • Tyrosine 3-Monooxygenase / metabolism*

Substances

  • Amyloid beta-Peptides
  • Glutamic Acid
  • Tyrosine 3-Monooxygenase